Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Nov 1, 2025
Date Accepted: Jan 29, 2026
AI Agents and epidemic intelligence of Respiratory Infectious Diseases: Towards a Conceptual Framework Integrating Decision Support
ABSTRACT
Background:
Traditional epidemic intelligence relies heavily on human epidemiologists for data interpretation and reporting, which makes it resource-intensive, slow to respond, and vulnerable to variability in professional expertise.
Objective:
To overcome these limitations, we propose an expanded epidemic intelligence quadripartite framework that extends the classical trinity of surveillance, risk assessment, and early warning with a fourth pillar: decision support and intervention optimization through AI Agents.
Methods:
AI Agents act as “24/7 digital epidemiologists,” integrating heterogeneous signals from multi-source surveillance systems, conducting contextual risk assessment and adaptive forecasting, generating tailored early warnings, and providing actionable recommendations for targeted control. Embedding interpretability and human-in-the-loop oversight enhances trust and accountability.
Results:
The proposed AI-driven framework demonstrates the potential to enable continuous, adaptive, and data-driven epidemic intelligence operations by linking surveillance, assessment, and intervention in real time.
Conclusions:
Nonetheless, real-world deployment requires addressing challenges of data quality, interoperability, robustness, governance, and equity. If designed with transparency, inclusiveness, and resilience, AI Agents have the potential to transform epidemic intelligence into a continuously adaptive and globally connected system.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.